{"denoms":[{"counts":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"53"}],"units":"Participants"}],"groups":[{"description":"Lenalidomide 25 mg PI days 1-21 Cyclophosphamide 300 mg/m\\^2 PO days 1, 8, 15 Dexamethasone 40 mg PI days 1, 8, 15, 22","id":"BG000","title":"LCD (Cyclophosphamide 300 mg/m^2)"},{"description":"Lenalidomide 25 mg PI days 1-21 Cyclophosphamide 300 mg PO days 1, 8, 15 Dexamethasone 40 mg PI days 1, 8, 15, 22","id":"BG001","title":"LCD (Cyclophosphamide 300 mg)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"44","upperLimit":"79","value":"63.5"},{"groupId":"BG001","lowerLimit":"37","upperLimit":"82","value":"65"},{"groupId":"BG002","lowerLimit":"37","upperLimit":"82","value":"64"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"26"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"27"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"53"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"4"}]}],"title":"Stage IA - Low Cell Mass"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"18"}]}],"title":"Stage IIA - Intermediate Cell Mass"},{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"31"}]}],"title":"Stage IIIA/B - High Cell Mass"}],"paramType":"NUMBER","title":"Durie Salmon Stage","unitOfMeasure":"paricipants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"39"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"14"}]}],"title":"No"}],"paramType":"NUMBER","title":"Parameter of Hematologic Response - Serum M-spike >= 1 g/dL","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"35"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"18"}]}],"title":"No"}],"paramType":"NUMBER","title":"Parameter of Hematologic Response - Serum Immunoglobulin Free Light Chain >= 10 mg/dL","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"16"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"37"}]}],"title":"No"}],"paramType":"NUMBER","title":"Parameter of Hematologic Response - Urine M-Spike >= 200 mg/24 hours","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"31"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"22"}]}],"title":"No"}],"paramType":"NUMBER","title":"Parameter of Hematologic Response - Bone Marrow Plasma Cells > 30%","unitOfMeasure":"participants"}]}